HR Execs on the Move

Ariosa Diagnostics

www.ariosadx.com

 
Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the Harmony™ Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The Harmony™ Prenatal Test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.ariosadx.com
  • 5945 Optical Ct
    San Jose, CA USA 95138-1400
  • Phone: 408.229.7500

Executives

Name Title Contact Details

Similar Companies

axialHealthcare

axialHealthcare offers an evidence-driven, predictive solution that limits opioid misuse and optimizes care for patients with pain or opioid use disorder.

Resolution Health Strategies

Resolution Health Strategies is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MediMedia Information Technologies

MediMedia Information Technologies (MMIT) was founded to assist health plans in the printing and distribution of their formulary documents. Over the last 25 years, MMIT has expanded and strengthened its relationships throughout the industry, developed innovative technology, and capitalized on trends to become the leading provider of multichannel formulary information solutions.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III

Standard Homeopathic Co (Hylands)

Standard Homeopathic Co (Hylands) is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Carson, CA. To find more information about Standard Homeopathic Co (Hylands), please visit www.hylands.com